Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-06

FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (TruPharma LLC)

View source ↗

Summary

The FDA approved an Original Application for oxybutynin chloride from TruPharma LLC. This is a generic formulation for the treatment of overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

ORIG AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)